PROM1 and hepatocellular carcinoma: The findings from this study have shown the combinatorial treatment of CD133 aptamer-DOX and autophagy inhibition leads to enhanced elimination of the bulk HCC cells and more importantly, the cancer stem cell population of HCC cells compared to free DOX.